Seattle Times: Pangu Technology's clinical trials seriously violated medical regulations, and it took less than half a year from the emergence of their technology to the final clinical treatment, which not only violated the international clinical trial rules on the treatment of malignant tumors, but also violated Xia Guo's own clinical trial rules. We have reason to suspect that the clinical trials of Pangu Technology are just a simple procedure, and we have reason to suspect that Pangu Technology's technology comes from the United States.

The New York Times: The New York court accepted the infringement case of Pangu Technology's inhibition of gene expression therapy, and Bristol-Myers Squibb has provided sufficient evidence, and if Pangu Technology does not sue, the court will try in absentia. In addition, Squibb also appealed to more than 20 international intellectual property organizations in the case, and asked the relevant departments of Xia to face up to Squibb's request and stop the treatment qualification of Pangu Technology's related technologies.

After the news of the New York Times came out, many Western media rushed to report it.

Several well-known medical institutes, including the Stanford Institute for Molecular Medicine, the Mayo Clinic, the Miffel Cancer Center and the Institute, have followed the progress.

They expressed their skepticism after the Pangu Science paper came out, and they even doubted the authenticity of the "Gene Expression" paper published in the journal "Cell".

At the same time, the FDA also officially issued an investigation notice against Pangu Technology, and the reason for the FDA's suspicion of Pangu Technology is that the physical indicators of the patients before and after treatment in Pangu Science and Technology's paper, as well as the treatment methods are similar to those after nivolumab treatment.

Gao Siqi came to Xiao Ming's office with the FDA's investigation notice and said: "The people of the United States are going crazy!"

Qian Yi, who was talking to Xiao Ming about things, looked at the investigation notice and said, "What are they thinking? Pangu Technology doesn't have any business in the United States, and a department in the United States can investigate the company in the Xia Kingdom?"

"Squibb's nivolumab has been banned globally, and the FDA has asked us to stop suppressing gene therapy," Gao said. ”

Qian Yi asked a little strangely: "Nivolumab has stopped selling globally?

Xiao Ming knew what Gao Siqi was trying to say, and he said: "The FDA and more than 20 intellectual property organizations around the world have launched an investigation against us, which should not only be the behavior of Squibb alone, but the behavior of the entire medical community in the United States. Squibb's loss of a newly launched nivolumab sale in exchange for Xia Guo's loss of a treatment that changed the global medical industry, is quite a good deal!"

Gao Siqi also added: "Now I understand the calculation of the rice company thoroughly. Squibb has many cancer-targeted drugs, even if nivolumab is no longer sold for the time being, there are still many alternative cancer-like targeted drugs, and there is almost no loss of profit for them, what is lost is only the survival probability of patients, those cancer patients will buy other Squibb drugs even if they can't buy nivolumab, but what Pangu Technology and the whole Huaguo have lost is the opportunity to inhibit the development of gene therapy. ”

Qian Yi asked, "These pharmaceutical companies and medical departments in the United States are so bloody? Don't they care about the survival of patients?"

Xiao Ming said with a smile: "Bloody? Which pharmaceutical company doesn't rely on blood to make a fortune? In the United States, cancer only has life expectancy, and there is no 100% treatment success, as long as the interests are not damaged, early death and late death are no different for these pharmaceutical companies." ”

Gao Siqi said: "According to the agreement of a number of intellectual property organizations, the relevant departments of Xia Guo should respond to them, and we of Pangu Technology will not make any response anyway." I'm afraid of a war of words with the United States, and I can't tell for a few years. ”

"Here comes the news. Qian Yi said with a swipe on her phone.

On Weibo, Xia Guo's media have spoken out against the FDA's notice, in addition to stern refutation, there is also an accusation that the laws of the United States cannot govern Xia Guo's enterprises.

Qian Yi handed the phone to Xiao Ming.

In addition to Xia Guo's media's refutation of the FDA notice, many netizens are also speaking out for Pangu Technology.

"The people of the United States are so disgusting! How to use the laws of the United States to demand the company of the Xia Kingdom. ”

"We don't use the operating system of the United States, how can we still say that we infringe intellectual property rights?"

"You just can't see us, right?"

"We must be saying that we are infringing on intellectual property rights! Imported targeted drugs will cost tens of thousands of dollars a month, and our technology will be treated for 300,000 or 400,000 yuan.

The Affiliated Hospital of Jiangcheng University also spoke out for Pangu Technology, and more than a dozen oncology experts said in the announcement of the affiliated hospital: "Pangu Technology, an inhibition gene expression therapy, has independent intellectual property rights, and is a new generation of nausea tumor therapy that is advanced in targeted therapy. Jiangcheng University will not stop using this technology to treat patients. ”

Xiao Ming read the news and said: "The matter of Pangu Technology will be solved by Pangu Technology itself, and we will learn to deal with Westerners from this matter." ”

Xiao Ming arranged a task for Gao Siqi and said: "Don't care about anything, go according to the plan." We have no business in the United States, and we will not be afraid of any investigation and trial of him. Also, if Xia Guo really accepts the conditions of the United States and prohibits the use of suppressive gene therapy in the medical community of Xia Guo, then I think Pangu Group can also move. ”

Xiao Ming's words are very serious, this matter is a test for Pangu Technology, and it is also a test for Xia Guo's technological confidence.

However, with Xiao Ming's instructions, Gao Siqi was able to work more boldly.

The first is to increase the production capacity of inhibitors, and the second is to cooperate with the Affiliated Hospital of Jiangcheng University to expand the admission of patients.

Xiao Ming also made an agreement with the Affiliated Hospital of Jiangda that after the Affiliated Hospital of Jiangda was full, it would spread outward with the Affiliated Hospital of Jiangda as the center, and send technicians to other tertiary hospitals, so that patients from all over the country could be treated at their doorsteps.

The Affiliated Hospital of Jiangcheng University also said that it would actively communicate with the higher authorities to strive for the non-implementation of the technical moratorium.

Many patients are very panicked after seeing foreign media reports and various news on the Internet, if it is really forbidden to suppress gene expression therapy, what should patients do?

Many people left messages under Pangu Technology to ask for the latest news.

"Why do the people of the Mi country manage the patients of our Xia Kingdom!"

"Don't forbid it! I just registered for my father!"

"If joining the International Intellectual Property Organization has such an impact on the Xia Congress, why should we join?"

In response to the patients' questions, Pangu Technology replied in a unified manner: "We will not give up on any patient. ”

.。 m.